Project
Illumina Body Map 2
Navigation
Downloads
Results for POU2F2_POU3F1
Z-value: 3.94
Motif logo
Transcription factors associated with POU2F2_POU3F1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
POU2F2
|
ENSG00000028277.16 | POU class 2 homeobox 2 |
|
POU3F1
|
ENSG00000185668.5 | POU class 3 homeobox 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| POU2F2 | hg19_v2_chr19_-_42636617_42636632 | 0.59 | 3.3e-04 | Click! |
| POU3F1 | hg19_v2_chr1_-_38512450_38512474 | -0.36 | 4.2e-02 | Click! |
Activity profile of POU2F2_POU3F1 motif
Sorted Z-values of POU2F2_POU3F1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr14_-_106552755 | 38.56 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
| chr14_-_106692191 | 35.70 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
| chr14_-_106573756 | 34.56 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
| chr14_-_106994333 | 32.22 |
ENST00000390624.2
|
IGHV3-48
|
immunoglobulin heavy variable 3-48 |
| chr14_-_106791536 | 31.61 |
ENST00000390613.2
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
| chr16_+_32077386 | 30.26 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
| chr14_-_106610852 | 30.11 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
| chr14_-_106586656 | 29.69 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
| chr16_+_33629600 | 29.47 |
ENST00000562905.2
|
IGHV3OR16-13
|
immunoglobulin heavy variable 3/OR16-13 (non-functional) |
| chr14_-_107114267 | 28.10 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr14_-_106622419 | 27.62 |
ENST00000390604.2
|
IGHV3-16
|
immunoglobulin heavy variable 3-16 (non-functional) |
| chr16_+_33020496 | 26.76 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
| chr22_+_22453093 | 25.23 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
| chr16_-_33647696 | 24.89 |
ENST00000558425.1
ENST00000569103.2 |
RP11-812E19.9
|
Uncharacterized protein |
| chr14_-_106845789 | 24.47 |
ENST00000390617.2
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional) |
| chr14_-_106816253 | 23.99 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
| chr14_-_107199464 | 23.70 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
| chr14_-_106518922 | 22.57 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
| chr2_-_89399845 | 21.88 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
| chr16_+_33006369 | 21.85 |
ENST00000425181.3
|
IGHV3OR16-10
|
immunoglobulin heavy variable 3/OR16-10 (non-functional) |
| chr2_-_89247338 | 21.16 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr14_-_107013465 | 20.84 |
ENST00000390625.2
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
| chr14_-_107211459 | 20.79 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
| chr2_+_90259593 | 20.66 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
| chr21_+_10862622 | 19.97 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
| chr2_+_89196746 | 18.91 |
ENST00000390244.2
|
IGKV5-2
|
immunoglobulin kappa variable 5-2 |
| chr16_+_32063311 | 18.77 |
ENST00000426099.1
|
AC142381.1
|
AC142381.1 |
| chr14_-_106926724 | 18.71 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
| chr2_+_90121477 | 18.26 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
| chr14_-_107078851 | 17.89 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
| chr2_-_89568263 | 17.57 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
| chr2_+_89952792 | 17.28 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
| chr15_-_20193370 | 16.58 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
| chr2_-_89340242 | 16.30 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chr22_+_23089870 | 16.15 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
| chr2_-_89545079 | 16.13 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
| chr2_+_90192768 | 16.04 |
ENST00000390275.2
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
| chr16_+_33605231 | 15.85 |
ENST00000570121.2
|
IGHV3OR16-12
|
immunoglobulin heavy variable 3/OR16-12 (non-functional) |
| chr2_+_114163945 | 14.49 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
| chr2_+_90248739 | 14.01 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
| chr15_-_20170354 | 13.61 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
| chr22_+_22764088 | 13.19 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
| chr14_-_107170409 | 13.00 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
| chr22_+_22735135 | 12.96 |
ENST00000390297.2
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
| chr14_-_107283278 | 12.90 |
ENST00000390639.2
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional) |
| chr14_-_107049312 | 12.27 |
ENST00000390627.2
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
| chr14_-_106725723 | 12.08 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr2_+_90211643 | 11.97 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
| chr2_-_89266286 | 11.94 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
| chr2_-_89417335 | 11.71 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chr14_-_106539557 | 11.42 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
| chr22_+_22385332 | 11.29 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
| chr2_+_90139056 | 10.93 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr2_-_89619904 | 10.75 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
| chr22_+_22712087 | 10.70 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
| chr22_+_23029188 | 10.59 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
| chr2_+_90273679 | 10.54 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
| chr3_+_151591422 | 10.51 |
ENST00000362032.5
|
SUCNR1
|
succinate receptor 1 |
| chr22_+_23040274 | 10.51 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
| chr2_-_89327228 | 10.45 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
| chr2_+_90198535 | 10.12 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
| chr22_+_23154239 | 10.03 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
| chr22_+_23010756 | 10.03 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
| chr22_+_23063100 | 10.03 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
| chr7_-_142511084 | 9.98 |
ENST00000417977.2
|
TRBV30
|
T cell receptor beta variable 30 (gene/pseudogene) |
| chr14_-_106866934 | 9.89 |
ENST00000390618.2
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional) |
| chr22_+_23077065 | 9.79 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
| chr2_+_89975669 | 9.61 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
| chr22_+_23165153 | 9.54 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
| chrX_-_48776292 | 9.53 |
ENST00000376509.4
|
PIM2
|
pim-2 oncogene |
| chr22_+_22930626 | 9.43 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
| chr4_-_71532339 | 9.35 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr4_-_71532668 | 9.29 |
ENST00000510437.1
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr4_-_71532601 | 8.96 |
ENST00000510614.1
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr4_-_71532207 | 8.93 |
ENST00000543780.1
ENST00000391614.3 |
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr2_+_89901292 | 8.52 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr2_+_89923550 | 8.38 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
| chr2_-_89459813 | 8.32 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr22_+_22550113 | 8.23 |
ENST00000390285.3
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
| chr2_+_89998789 | 8.16 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr22_+_23161491 | 7.82 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 (gene/pseudogene) |
| chr14_-_107131560 | 7.22 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
| chr3_+_98250743 | 7.21 |
ENST00000284311.3
|
GPR15
|
G protein-coupled receptor 15 |
| chr2_+_90043607 | 7.15 |
ENST00000462693.1
|
IGKV2D-24
|
immunoglobulin kappa variable 2D-24 (non-functional) |
| chr16_+_23847339 | 7.14 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
| chr6_+_26251835 | 7.06 |
ENST00000356350.2
|
HIST1H2BH
|
histone cluster 1, H2bh |
| chr2_+_90060377 | 7.03 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
| chr16_+_23847355 | 7.02 |
ENST00000498058.1
|
PRKCB
|
protein kinase C, beta |
| chrX_+_12993336 | 7.02 |
ENST00000380635.1
|
TMSB4X
|
thymosin beta 4, X-linked |
| chr6_-_31560729 | 6.70 |
ENST00000340027.5
ENST00000376073.4 ENST00000376072.3 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
| chr14_-_107219365 | 6.58 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
| chr16_+_23847267 | 6.54 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
| chr4_-_108204904 | 6.42 |
ENST00000510463.1
|
DKK2
|
dickkopf WNT signaling pathway inhibitor 2 |
| chr21_+_39644395 | 6.11 |
ENST00000398934.1
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
| chr8_-_134114721 | 5.76 |
ENST00000522119.1
ENST00000523610.1 ENST00000521302.1 ENST00000519558.1 ENST00000519747.1 ENST00000517648.1 |
SLA
|
Src-like-adaptor |
| chr6_-_26216872 | 5.63 |
ENST00000244601.3
|
HIST1H2BG
|
histone cluster 1, H2bg |
| chr5_+_158527630 | 5.52 |
ENST00000523301.1
|
RP11-175K6.1
|
RP11-175K6.1 |
| chr6_+_26273144 | 5.47 |
ENST00000377733.2
|
HIST1H2BI
|
histone cluster 1, H2bi |
| chr4_-_108204846 | 5.34 |
ENST00000513208.1
|
DKK2
|
dickkopf WNT signaling pathway inhibitor 2 |
| chrX_+_12993202 | 5.32 |
ENST00000451311.2
ENST00000380636.1 |
TMSB4X
|
thymosin beta 4, X-linked |
| chr7_-_27153454 | 5.28 |
ENST00000522456.1
|
HOXA3
|
homeobox A3 |
| chr8_+_19796381 | 5.26 |
ENST00000524029.1
ENST00000522701.1 ENST00000311322.8 |
LPL
|
lipoprotein lipase |
| chr2_-_89597542 | 5.08 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
| chr1_-_149814478 | 5.06 |
ENST00000369161.3
|
HIST2H2AA3
|
histone cluster 2, H2aa3 |
| chr5_-_141030943 | 5.05 |
ENST00000522783.1
ENST00000519800.1 ENST00000435817.2 |
FCHSD1
|
FCH and double SH3 domains 1 |
| chr8_-_134114887 | 5.02 |
ENST00000519341.1
|
SLA
|
Src-like-adaptor |
| chr8_-_134114866 | 4.93 |
ENST00000524345.1
|
SLA
|
Src-like-adaptor |
| chr1_+_117297007 | 4.91 |
ENST00000369478.3
ENST00000369477.1 |
CD2
|
CD2 molecule |
| chr1_+_149822620 | 4.85 |
ENST00000369159.2
|
HIST2H2AA4
|
histone cluster 2, H2aa4 |
| chr8_+_56792377 | 4.80 |
ENST00000520220.2
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
| chr22_+_23114284 | 4.78 |
ENST00000390313.2
|
IGLV3-12
|
immunoglobulin lambda variable 3-12 |
| chr22_+_22781853 | 4.70 |
ENST00000390300.2
|
IGLV5-37
|
immunoglobulin lambda variable 5-37 |
| chr14_+_22217447 | 4.64 |
ENST00000390427.3
|
TRAV5
|
T cell receptor alpha variable 5 |
| chr5_-_66492562 | 4.50 |
ENST00000256447.4
|
CD180
|
CD180 molecule |
| chr2_+_90458201 | 4.50 |
ENST00000603238.1
|
CH17-132F21.1
|
Uncharacterized protein |
| chr1_+_206730484 | 4.43 |
ENST00000304534.8
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5 |
| chr4_-_25865159 | 4.40 |
ENST00000502949.1
ENST00000264868.5 ENST00000513691.1 ENST00000514872.1 |
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
| chr8_+_56792355 | 4.39 |
ENST00000519728.1
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
| chr14_+_22293618 | 4.29 |
ENST00000390432.2
|
TRAV10
|
T cell receptor alpha variable 10 |
| chr6_-_27782548 | 4.25 |
ENST00000333151.3
|
HIST1H2AJ
|
histone cluster 1, H2aj |
| chr3_-_112360116 | 4.09 |
ENST00000206423.3
ENST00000439685.2 |
CCDC80
|
coiled-coil domain containing 80 |
| chr22_+_23046750 | 4.08 |
ENST00000390307.2
|
IGLV3-22
|
immunoglobulin lambda variable 3-22 (gene/pseudogene) |
| chr16_+_53164956 | 4.04 |
ENST00000563410.1
|
CHD9
|
chromodomain helicase DNA binding protein 9 |
| chr12_-_31479045 | 3.97 |
ENST00000539409.1
ENST00000395766.1 |
FAM60A
|
family with sequence similarity 60, member A |
| chr2_+_90108504 | 3.95 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
| chr4_+_40194570 | 3.87 |
ENST00000507851.1
|
RHOH
|
ras homolog family member H |
| chr6_-_27114577 | 3.86 |
ENST00000356950.1
ENST00000396891.4 |
HIST1H2BK
|
histone cluster 1, H2bk |
| chr6_+_143999185 | 3.85 |
ENST00000542769.1
ENST00000397980.3 |
PHACTR2
|
phosphatase and actin regulator 2 |
| chr19_+_17858509 | 3.69 |
ENST00000594202.1
ENST00000252771.7 ENST00000389133.4 |
FCHO1
|
FCH domain only 1 |
| chr6_-_149806105 | 3.67 |
ENST00000389942.5
ENST00000416573.2 ENST00000542614.1 ENST00000409806.3 |
ZC3H12D
|
zinc finger CCCH-type containing 12D |
| chr22_-_24096562 | 3.65 |
ENST00000398465.3
|
VPREB3
|
pre-B lymphocyte 3 |
| chr6_+_27775899 | 3.64 |
ENST00000358739.3
|
HIST1H2AI
|
histone cluster 1, H2ai |
| chr6_-_55739542 | 3.62 |
ENST00000446683.2
|
BMP5
|
bone morphogenetic protein 5 |
| chr8_-_134115118 | 3.53 |
ENST00000395352.3
ENST00000338087.5 |
SLA
|
Src-like-adaptor |
| chr7_-_27183263 | 3.52 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
| chr1_+_207669573 | 3.49 |
ENST00000400960.2
ENST00000534202.1 |
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group) |
| chr21_+_39644305 | 3.47 |
ENST00000398930.1
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
| chr1_+_207669495 | 3.44 |
ENST00000367052.1
ENST00000367051.1 ENST00000367053.1 |
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group) |
| chrX_+_134654540 | 3.43 |
ENST00000370752.4
|
DDX26B
|
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26B |
| chr1_+_149858461 | 3.42 |
ENST00000331380.2
|
HIST2H2AC
|
histone cluster 2, H2ac |
| chr5_-_2751762 | 3.41 |
ENST00000302057.5
ENST00000382611.6 |
IRX2
|
iroquois homeobox 2 |
| chr19_-_44171817 | 3.39 |
ENST00000593714.1
|
PLAUR
|
plasminogen activator, urokinase receptor |
| chr4_-_154710210 | 3.34 |
ENST00000274063.4
|
SFRP2
|
secreted frizzled-related protein 2 |
| chrX_+_99839799 | 3.33 |
ENST00000373031.4
|
TNMD
|
tenomodulin |
| chr8_-_125827922 | 3.24 |
ENST00000533516.1
|
RP11-1082L8.4
|
RP11-1082L8.4 |
| chr6_-_128222103 | 3.19 |
ENST00000434358.1
ENST00000543064.1 ENST00000368248.2 |
THEMIS
|
thymocyte selection associated |
| chr7_+_50348268 | 3.19 |
ENST00000438033.1
ENST00000439701.1 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
| chr3_+_63638339 | 3.13 |
ENST00000343837.3
ENST00000469440.1 |
SNTN
|
sentan, cilia apical structure protein |
| chr22_-_24096630 | 3.13 |
ENST00000248948.3
|
VPREB3
|
pre-B lymphocyte 3 |
| chr6_+_37137939 | 3.11 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
| chr1_+_207669613 | 3.09 |
ENST00000367049.4
ENST00000529814.1 |
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group) |
| chr17_+_38171614 | 3.06 |
ENST00000583218.1
ENST00000394149.3 |
CSF3
|
colony stimulating factor 3 (granulocyte) |
| chr16_-_88752889 | 3.02 |
ENST00000332281.5
|
SNAI3
|
snail family zinc finger 3 |
| chr17_-_47841485 | 2.97 |
ENST00000506156.1
ENST00000240364.2 |
FAM117A
|
family with sequence similarity 117, member A |
| chr12_+_10124001 | 2.95 |
ENST00000396507.3
ENST00000304361.4 ENST00000434319.2 |
CLEC12A
|
C-type lectin domain family 12, member A |
| chr10_-_10836865 | 2.95 |
ENST00000446372.2
|
SFTA1P
|
surfactant associated 1, pseudogene |
| chr2_+_68962014 | 2.93 |
ENST00000467265.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
| chr5_+_2752334 | 2.92 |
ENST00000505778.1
ENST00000515640.1 ENST00000397835.4 |
C5orf38
|
chromosome 5 open reading frame 38 |
| chr19_-_50169064 | 2.92 |
ENST00000593337.1
ENST00000598808.1 ENST00000600453.1 ENST00000593818.1 ENST00000597198.1 ENST00000601809.1 ENST00000377139.3 |
IRF3
|
interferon regulatory factor 3 |
| chr17_+_62461569 | 2.91 |
ENST00000603557.1
ENST00000605096.1 |
MILR1
|
mast cell immunoglobulin-like receptor 1 |
| chr1_+_201979645 | 2.82 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chr12_-_31479107 | 2.81 |
ENST00000542983.1
|
FAM60A
|
family with sequence similarity 60, member A |
| chr7_+_18535321 | 2.78 |
ENST00000413380.1
ENST00000430454.1 |
HDAC9
|
histone deacetylase 9 |
| chr7_+_18535346 | 2.77 |
ENST00000405010.3
ENST00000406451.4 ENST00000428307.2 |
HDAC9
|
histone deacetylase 9 |
| chr21_-_36260980 | 2.77 |
ENST00000344691.4
ENST00000358356.5 |
RUNX1
|
runt-related transcription factor 1 |
| chr19_-_18508396 | 2.77 |
ENST00000595840.1
ENST00000339007.3 |
LRRC25
|
leucine rich repeat containing 25 |
| chr17_+_38171681 | 2.77 |
ENST00000225474.2
ENST00000331769.2 ENST00000394148.3 ENST00000577675.1 |
CSF3
|
colony stimulating factor 3 (granulocyte) |
| chr19_-_50168962 | 2.75 |
ENST00000599223.1
ENST00000593922.1 ENST00000600022.1 ENST00000596765.1 ENST00000599144.1 ENST00000596822.1 ENST00000598108.1 ENST00000601373.1 ENST00000595034.1 ENST00000601291.1 |
IRF3
|
interferon regulatory factor 3 |
| chr19_-_47291843 | 2.71 |
ENST00000542575.2
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5 |
| chr3_-_87040233 | 2.67 |
ENST00000398399.2
|
VGLL3
|
vestigial like 3 (Drosophila) |
| chr10_-_10836919 | 2.64 |
ENST00000602763.1
ENST00000415590.2 ENST00000434919.2 |
SFTA1P
|
surfactant associated 1, pseudogene |
| chr18_-_52989525 | 2.59 |
ENST00000457482.3
|
TCF4
|
transcription factor 4 |
| chr19_+_55128576 | 2.56 |
ENST00000396331.1
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
| chr6_+_27833034 | 2.51 |
ENST00000357320.2
|
HIST1H2AL
|
histone cluster 1, H2al |
| chr1_-_149859466 | 2.49 |
ENST00000331128.3
|
HIST2H2AB
|
histone cluster 2, H2ab |
| chr3_-_46069223 | 2.46 |
ENST00000309285.3
|
XCR1
|
chemokine (C motif) receptor 1 |
| chr16_-_89008211 | 2.41 |
ENST00000569464.1
ENST00000569443.1 |
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
| chr6_-_53013620 | 2.40 |
ENST00000259803.7
|
GCM1
|
glial cells missing homolog 1 (Drosophila) |
| chr11_-_75917569 | 2.38 |
ENST00000322563.3
|
WNT11
|
wingless-type MMTV integration site family, member 11 |
| chr19_+_35820064 | 2.37 |
ENST00000341773.6
ENST00000600131.1 ENST00000270311.6 ENST00000595780.1 ENST00000597916.1 ENST00000593867.1 ENST00000600424.1 ENST00000599811.1 ENST00000536635.2 ENST00000085219.5 ENST00000544992.2 ENST00000419549.2 |
CD22
|
CD22 molecule |
| chr4_-_123377880 | 2.37 |
ENST00000226730.4
|
IL2
|
interleukin 2 |
| chr19_-_40931891 | 2.32 |
ENST00000357949.4
|
SERTAD1
|
SERTA domain containing 1 |
| chr14_+_103573853 | 2.32 |
ENST00000560304.1
|
EXOC3L4
|
exocyst complex component 3-like 4 |
| chr17_+_72733350 | 2.32 |
ENST00000392613.5
ENST00000392612.3 ENST00000392610.1 |
RAB37
|
RAB37, member RAS oncogene family |
| chr11_-_5248294 | 2.30 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
| chr11_-_118305921 | 2.28 |
ENST00000532619.1
|
RP11-770J1.4
|
RP11-770J1.4 |
| chr7_+_16793160 | 2.27 |
ENST00000262067.4
|
TSPAN13
|
tetraspanin 13 |
| chr5_+_2752258 | 2.27 |
ENST00000334000.3
|
C5orf38
|
chromosome 5 open reading frame 38 |
| chr3_-_87039662 | 2.24 |
ENST00000494229.1
|
VGLL3
|
vestigial like 3 (Drosophila) |
| chr11_-_129872672 | 2.21 |
ENST00000531431.1
ENST00000527581.1 |
PRDM10
|
PR domain containing 10 |
| chr5_-_175965008 | 2.20 |
ENST00000537487.1
|
RNF44
|
ring finger protein 44 |
| chr6_+_6588902 | 2.18 |
ENST00000230568.4
|
LY86
|
lymphocyte antigen 86 |
| chr12_-_51664058 | 2.14 |
ENST00000605627.1
|
SMAGP
|
small cell adhesion glycoprotein |
| chr5_+_2752216 | 2.14 |
ENST00000457752.2
|
C5orf38
|
chromosome 5 open reading frame 38 |
| chr3_+_63638372 | 2.13 |
ENST00000496807.1
|
SNTN
|
sentan, cilia apical structure protein |
| chr12_+_122064398 | 2.12 |
ENST00000330079.7
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1 |
| chr19_+_39903185 | 2.12 |
ENST00000409794.3
|
PLEKHG2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
| chr4_+_40194609 | 2.09 |
ENST00000508513.1
|
RHOH
|
ras homolog family member H |
| chr12_+_10124110 | 2.08 |
ENST00000350667.4
|
CLEC12A
|
C-type lectin domain family 12, member A |
| chr1_+_170632250 | 2.05 |
ENST00000367760.3
|
PRRX1
|
paired related homeobox 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of POU2F2_POU3F1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.8 | 1005.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 5.2 | 20.7 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 3.1 | 9.2 | GO:0070668 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 2.2 | 6.7 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 1.7 | 3.3 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.5 | 12.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 1.5 | 4.6 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
| 1.2 | 3.5 | GO:0060435 | bronchiole development(GO:0060435) |
| 1.2 | 259.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 1.1 | 3.3 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.9 | 6.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.9 | 3.4 | GO:0072086 | specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
| 0.7 | 4.9 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.7 | 2.7 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.7 | 5.3 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.6 | 1.9 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.6 | 2.6 | GO:0035548 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
| 0.6 | 2.4 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 0.6 | 2.4 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.6 | 1.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.6 | 5.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.6 | 2.3 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 0.5 | 1.9 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.5 | 1.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.4 | 2.2 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.4 | 1.3 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) negative regulation of B cell differentiation(GO:0045578) positive regulation of ovulation(GO:0060279) |
| 0.4 | 1.7 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.4 | 3.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.4 | 5.9 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
| 0.4 | 5.7 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.4 | 5.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.4 | 1.5 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.3 | 4.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.3 | 1.4 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.3 | 0.7 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.3 | 1.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 | 1.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.3 | 6.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.3 | 2.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.3 | 0.9 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.3 | 1.6 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.3 | 1.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 | 1.6 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
| 0.2 | 0.5 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
| 0.2 | 3.0 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.2 | 3.4 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.2 | 1.6 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 0.2 | 0.9 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.2 | 1.1 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.2 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 | 1.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.2 | 2.9 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.2 | 1.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.2 | 3.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.2 | 3.2 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.2 | 2.1 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.2 | 2.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.2 | 1.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.2 | 1.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.2 | 3.0 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.2 | 2.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.2 | 1.4 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.1 | 3.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.1 | 19.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 3.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 0.5 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.1 | 7.2 | GO:0072678 | T cell migration(GO:0072678) |
| 0.1 | 1.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 2.3 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 0.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.1 | 3.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 1.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 7.2 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.1 | 0.3 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 | 0.3 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
| 0.1 | 9.5 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
| 0.1 | 3.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 1.7 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 6.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.1 | 1.8 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 2.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.1 | 1.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.1 | 0.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.1 | 2.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 | 2.4 | GO:0030728 | ovulation(GO:0030728) |
| 0.1 | 0.4 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 | 0.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.3 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.1 | 0.3 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.1 | 1.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 0.3 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 | 0.5 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.1 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 1.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 1.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 2.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 | 0.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.0 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.0 | 0.8 | GO:0007379 | segment specification(GO:0007379) |
| 0.0 | 0.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.0 | 1.5 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.0 | 0.7 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.0 | 0.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 2.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 1.8 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.0 | 1.5 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
| 0.0 | 5.5 | GO:0006342 | chromatin silencing(GO:0006342) |
| 0.0 | 0.5 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.0 | 0.8 | GO:0030903 | notochord development(GO:0030903) |
| 0.0 | 0.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 | 4.9 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 | 0.5 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.0 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 | 1.4 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.0 | 0.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.0 | 1.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.0 | 2.3 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.0 | 6.0 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.0 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 4.4 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
| 0.0 | 1.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 | 0.2 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.0 | 0.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.0 | 3.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 | 1.0 | GO:0006811 | ion transport(GO:0006811) |
| 0.0 | 1.6 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.0 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.4 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 | 2.3 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
| 0.0 | 0.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 | 0.1 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.0 | 1.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 | 0.9 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.4 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.0 | 0.4 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.0 | 0.4 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.4 | 451.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 1.5 | 9.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.8 | 182.2 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.4 | 1.3 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.3 | 5.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.3 | 12.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.3 | 2.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.2 | 5.3 | GO:0042627 | chylomicron(GO:0042627) |
| 0.2 | 3.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.2 | 1.5 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.2 | 6.8 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.2 | 1.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.2 | 3.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.2 | 1.5 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.1 | 0.4 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.1 | 0.9 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.1 | 317.0 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 0.4 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.1 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
| 0.1 | 1.9 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.1 | 4.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 1.1 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 3.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 0.6 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.1 | 1.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.1 | 2.9 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 5.4 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 0.9 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.1 | 7.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 0.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.1 | 7.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 4.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 14.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 2.3 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 3.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 9.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 1.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
| 0.0 | 0.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.0 | 3.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 3.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 1.6 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
| 0.0 | 1.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 0.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.0 | 0.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.0 | 153.0 | GO:0005576 | extracellular region(GO:0005576) |
| 0.0 | 1.2 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 0.8 | GO:0031430 | M band(GO:0031430) |
| 0.0 | 1.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.0 | 1.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 1.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.0 | 1.0 | GO:0005903 | brush border(GO:0005903) |
| 0.0 | 0.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 2.4 | GO:0000922 | spindle pole(GO:0000922) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.9 | 451.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 5.2 | 20.7 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 3.4 | 760.4 | GO:0003823 | antigen binding(GO:0003823) |
| 3.3 | 10.0 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 1.4 | 11.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 1.3 | 5.3 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.9 | 2.6 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 0.7 | 11.8 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.5 | 4.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.5 | 3.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.4 | 3.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.4 | 4.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.4 | 2.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.3 | 2.7 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.3 | 7.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.2 | 3.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 5.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.2 | 0.7 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.2 | 1.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.2 | 1.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.2 | 3.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 12.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 6.9 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.2 | 2.1 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 1.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.2 | 6.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.2 | 1.3 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.2 | 17.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.2 | 3.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 0.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.1 | 2.9 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.1 | 1.4 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.1 | 0.5 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.1 | 1.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 1.2 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 3.6 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 4.1 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 1.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 1.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 0.9 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.1 | 0.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.1 | 3.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 1.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 1.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 1.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 1.4 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 1.0 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.1 | 0.3 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.1 | 1.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 1.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 1.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 1.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 2.3 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.0 | 1.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.0 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.0 | 0.6 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.0 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.0 | 2.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.0 | 1.5 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 1.6 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 1.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.0 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.4 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.0 | 2.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 0.1 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.0 | 0.4 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.0 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.0 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.0 | 3.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.0 | 1.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.0 | 0.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.0 | 1.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 1.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 0.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.0 | 0.2 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.0 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 2.8 | GO:0070851 | growth factor receptor binding(GO:0070851) |
| 0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.0 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 2.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 20.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.3 | 10.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 1.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.2 | 12.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 9.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.1 | 3.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 5.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 14.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 2.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 15.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 7.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 1.3 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 2.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.0 | 1.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.0 | 4.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.0 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.0 | 5.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 2.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 1.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 2.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.0 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.0 | 2.0 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 1.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 7.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 9.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.4 | 19.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.3 | 10.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.3 | 7.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.2 | 3.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 5.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.2 | 9.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 7.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 3.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 2.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 1.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.1 | 1.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 1.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.1 | 1.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 3.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 1.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.1 | 1.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 5.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.0 | 4.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 3.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.0 | 3.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 2.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.0 | 0.8 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.0 | 1.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.0 | 1.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 1.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 1.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 1.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 1.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 4.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 4.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 0.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 0.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 2.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 2.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.0 | 1.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 1.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.0 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.0 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.0 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 0.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |